BACKGROUND: To prepare for national introduction of a pneumococcal conjugate vaccine of restricted valency, we studied nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants. METHODS: We studied 236 infants in 21 villages. We collected nasopharyngeal swab samples at birth, twice per month for 6 months, and every second month until 1 year of age. We studied time to acquisition and duration of pneumococcal carriage according to serotype. RESULTS: All infants carried S. pneumoniae at some point. Sixty-five serotypes were found, and the 5 most common serotypes (6B, 19F, 6A, 14, and 23F) accounted for 51% of isolates. The mean age at first acquisition of carriage was 33 days (95% confidence interval, 29-36 days). There were no significant differences in acquisition rates between the 6 most common serotypes (P = .067) or between vaccine serotypes, vaccine-related serotypes, or nonvaccine serotypes (P = .317). However, the duration of carriage differed significantly between the 6 most common serotypes (P = .004). The rate of reacquisition of carriage and the duration of carriage did not differ significantly between the 6 most common serotypes (P = .229 and P = .669 respectively). However, nonvaccine types were acquired faster (P = .004) and were carried for a shorter duration (P < .001) than were vaccine serotypes. A previous episode of serotype 14 carriage was associated with delayed reacquisition of this serotype (P = .005) and longer duration of carriage (P = .017). CONCLUSIONS: The data provided in this study regarding time to acquisition and duration of pneumococcal carriage in Gambian infants provide an important baseline for evaluating the impact of the introduction of a pneumococcal conjugate vaccine in The Gambia and elsewhere in Africa.
BACKGROUND: To prepare for national introduction of a pneumococcal conjugate vaccine of restricted valency, we studied nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants. METHODS: We studied 236 infants in 21 villages. We collected nasopharyngeal swab samples at birth, twice per month for 6 months, and every second month until 1 year of age. We studied time to acquisition and duration of pneumococcal carriage according to serotype. RESULTS: All infants carried S. pneumoniae at some point. Sixty-five serotypes were found, and the 5 most common serotypes (6B, 19F, 6A, 14, and 23F) accounted for 51% of isolates. The mean age at first acquisition of carriage was 33 days (95% confidence interval, 29-36 days). There were no significant differences in acquisition rates between the 6 most common serotypes (P = .067) or between vaccine serotypes, vaccine-related serotypes, or nonvaccine serotypes (P = .317). However, the duration of carriage differed significantly between the 6 most common serotypes (P = .004). The rate of reacquisition of carriage and the duration of carriage did not differ significantly between the 6 most common serotypes (P = .229 and P = .669 respectively). However, nonvaccine types were acquired faster (P = .004) and were carried for a shorter duration (P < .001) than were vaccine serotypes. A previous episode of serotype 14 carriage was associated with delayed reacquisition of this serotype (P = .005) and longer duration of carriage (P = .017). CONCLUSIONS: The data provided in this study regarding time to acquisition and duration of pneumococcal carriage in Gambian infants provide an important baseline for evaluating the impact of the introduction of a pneumococcal conjugate vaccine in The Gambia and elsewhere in Africa.
Authors: Gareth D H Turner; Charatdao Bunthi; Chizoba B Wonodi; Susan C Morpeth; Catherine S Molyneux; Sherif R Zaki; Orin S Levine; David R Murdoch; J Anthony G Scott Journal: Clin Infect Dis Date: 2012-04 Impact factor: 9.079
Authors: Juliana Lamaro-Cardoso; Ana Paula S de Lemos; Maria da Glória Carvalho; Fabiana Cristina Pimenta; Alexis Roundtree; Lorena Motta; Maria Aparecida Vieira; Sabrina Sgambatti; Licia Kamila Thörn; Vicente Pessoa-Junior; Ruth Minamisava; Lee H Harrison; Bernard W Beall; Maria Cristina de Cunto Brandileone; Ana Lucia Andrade Journal: J Med Microbiol Date: 2012-01-27 Impact factor: 2.472
Authors: Christian L Coles; Lakshmi Rahmathullah; Reba Kanungo; Joanne Katz; Debora Sandiford; Sheela Devi; R D Thulasiraj; James M Tielsch Journal: J Nutr Date: 2012-04-25 Impact factor: 4.798
Authors: Marcus H Leung; Kevin Bryson; Kathrin Freystatter; Bruno Pichon; Giles Edwards; Bambos M Charalambous; Stephen H Gillespie Journal: J Clin Microbiol Date: 2012-05-02 Impact factor: 5.948
Authors: Christian L Coles; Jeevan B Sherchand; Subarna K Khatry; Joanne Katz; Steven C Leclerq; Luke C Mullany; James M Tielsch Journal: Trop Med Int Health Date: 2009-06-28 Impact factor: 2.622
Authors: Alessia Melegaro; Yoon Hong Choi; Robert George; W John Edmunds; Elizabeth Miller; Nigel J Gay Journal: BMC Infect Dis Date: 2010-04-08 Impact factor: 3.090